ANTONIO HERNANDEZ MIJARES-rekin lankidetzan egindako argitalpenak (76)

2024

  1. Inflammation and weight change related to neurocognitive and functional impairment in diabetes and psychiatric disorders

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

2022

  1. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  2. Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders

    Acta Psychiatrica Scandinavica, Vol. 146, Núm. 3, pp. 215-226

  3. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2019

  1. Malnutrition impairs mitochondrial function and leukocyte activation

    Nutrition Journal, Vol. 18, Núm. 1

  2. Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

    Scientific Reports, Vol. 9, Núm. 1

  3. The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  4. The mitochondria-targeted antioxidant MitoQ modulates mitochondrial function and endoplasmic reticulum stress in pancreatic β cells exposed to hyperglycaemia

    Cellular Physiology and Biochemistry, Vol. 52, Núm. 2, pp. 186-197

2018

  1. Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells?

    Antioxidants and Redox Signaling, Vol. 28, Núm. 17, pp. 1562-1569

  2. Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

    Oncotarget, Vol. 9, Núm. 4, pp. 4522-4536

  3. Obesity impairs leukocyte-endothelium cell interactions and oxidative stress in humans

    European Journal of Clinical Investigation, Vol. 48, Núm. 8

  4. Pinitol alleviates systemic inflammatory cytokines in human obesity by a mechanism involving unfolded protein response and sirtuin 1

    Clinical Nutrition, Vol. 37, Núm. 6, pp. 2036-2044

2017

  1. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 17, pp. 1439-1445

  2. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients

    Free Radical Biology and Medicine, Vol. 108, pp. 155-162

  3. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte–endothelium interactions in PCOS

    Metabolism: Clinical and Experimental, Vol. 71, pp. 153-162

  4. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications

    Redox Biology, Vol. 11, pp. 637-645

  5. Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1556-1563

  6. Research update for articles published in EJCI in 2015

    European Journal of Clinical Investigation, Vol. 47, Núm. 10, pp. 775-788

2016

  1. Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?

    Antioxidants and Redox Signaling, Vol. 25, Núm. 2, pp. 108-115